EP2379067
Skömmtunaráætlun fyrir Fingolimod vegna meðferðar við heila-og mænusiggi
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
21.12.2009EP published:
2.9.2015EP application number:
09797234.3
EP translation filed:
9.11.2015Grant published:
15.12.2015EPO information:
European Patent Register
Max expiry date:
20.12.2029Expiry date:
20.12.2016
Title:
DOSAGE REGIMEN FOR FINGOLIMOD FOR THE TREATMENT OF MULTIPLE SCLEROSIS
Timeline
Today
21.12.2009EP application
2.9.2015EP Publication
9.11.2015Translation submitted
15.12.2015Registration published
20.12.2016Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Inventor
Name:
SCHMOUDER, RobertAddress:
East HanoverNJ, US
Name:
DUMORTIER, ThomasAddress:
Basel, CH
Name:
DAVID, OlivierAddress:
Basel, CH
Name:
LOOBY, MichaelAddress:
Basel, CH
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
139672 PDate:
22.12.2008Country:
US
Number:
218530 PDate:
19.6.2009Country:
US
Number:
246715 PDate:
29.9.2009Country:
US
Classification
Categories:
A61K 31/137, A61P 37/00, A61P 37/06, A61K 31/135, A61K 31/138, A61K 31/661, C07F 9/10
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 9.11.2015
Expires: 20.12.2016
Payer: PATICE, Ólafur Ragnarsson, hrl.